J. Ludwig
Molecular Biology · 2005–2006
A researcher in the Science corpus: 2 papers; trusts 5 researchers and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 30 citations into it; #6,839 of 17,773 by trust here, #7,574 by citations
- Oncology — 20 citations into it
Whom J. Ludwig trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts J. Ludwig overall
Papers from J. Ludwig's perspective
Ordered by how strongly the researchers J. Ludwig trusts endorse each paper. Same corpus, a different order for every researcher.
- Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. (New England Journal of Medicine)
- A molecular signature of metastasis in primary solid tumors (Nature Genetics)
- Molecular portraits of human breast tumours (Nature)
- Translating the Histone Code (Science)
- Emerging molecular markers of cancer (Nature Reviews. Cancer)
- A gene-expression signature as a predictor of survival in breast cancer. (New England Journal of Medicine)
- Revision of the American Joint Committee on Cancer staging system for breast cancer. (Journal of Clinical Oncology)
- Breast cancer classification and prognosis based on gene expression profiles from a population-based study (Proceedings of the National Academy of Sciences of the United States of America)
- [Serial analysis of gene expression]. (Yi chuan = Hereditas)
- Gene expression profiles of human breast cancer progression (Proceedings of the National Academy of Sciences of the United States of America)
Their papers
- Biomarkers in Cancer Staging, Prognosis and Treatment Selection (2005) — 1,676 citations
- Targeting multidrug resistance in cancer (2006) — 3,544 citations